Home › Myelodysplastic Syndromes › Illinois

Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Illinois

16 pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
at 40 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06577441

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

University of Chicago Comprehensive Cancer Center, Chicago

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06484062

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
OSF Saint Joseph Medical Center, Bloomington
at 54 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Orchard Healthcare Research Inc. (OHR) - Skokie, Skokie

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

University of Chicago, Duchossois Center for Advanced Medicine (DCAM), Chicago

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Lurie Children's Hospital-Chicago, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
at 6 pa

Nagre-recruitPhase 1/2

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

ILCC. Illinois Cancer Centers, Peoria

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06499285

Mosaic Trial for Stem Cell Transplant Recipients

Northwestern University Feinberg School of Medicine, Chicago

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06960993

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site, Decatur

Nagre-recruitPhase 1/2

Edad 16 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07155226

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

University of Illinois Cancer Center, Chicago

Nagre-recruitPhase 2

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06802315

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Northwestern University, Chicago

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT05732103

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Northwestern, Chicago

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

Nagre-recruitPhase 1

Edad 1 hanggang 40 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT05292664

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

University of Chicago Comprehensive Cancer Center, Chicago

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT05745285

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chicago

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT06501196

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.